GENERATION BIO CO. - COMMON STOCK

Generation Bio to Apply ctLNP Delivery Technology to Develop siRNA Therapeutics for T Cell-Driven Autoimmune Diseases

06 янв 2025 16:30:00 Источник Nasdaq GlobeNewswire

Generation Bio Reports Recent Business Highlights and Third Quarter 2024 Financial Results

06 ноя 2024 16:05:00 Источник Nasdaq GlobeNewswire

Generation Bio Announces the Presentation of Preclinical Data on ctLNP and iqDNA at the ESGCT 31st Annual Congress

22 окт 2024 06:59:00 Источник Nasdaq GlobeNewswire

Generation Bio to Present at the 2024 Cantor Global Healthcare Conference

12 сен 2024 16:05:00 Источник Nasdaq GlobeNewswire

Generation Bio Reports Second Quarter 2024 Financial Results

07 авг 2024 16:05:00 Источник Nasdaq GlobeNewswire

Generation Bio to Present at the Canaccord Genuity 44th Annual Growth Conference

06 авг 2024 06:59:00 Источник Nasdaq GlobeNewswire

Generation Bio to Present at the 2024 TD Cowen Genetic Medicines & RNA Summit

14 июн 2024 06:59:00 Источник Nasdaq GlobeNewswire

Generation Bio Announces Recent Business Highlights and First Quarter 2024 Financial Results

13 май 2024 16:05:00 Источник Nasdaq GlobeNewswire

Generation Bio Announces the Presentation of Preclinical Data on iqDNA and ctLNP Platforms at the ASGCT 27th Annual Meeting

09 май 2024 06:59:00 Источник Nasdaq GlobeNewswire

Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting

22 апр 2024 17:31:01 Источник Nasdaq GlobeNewswire

Generation Bio to Present at the 23rd Annual Needham Virtual Healthcare Conference

02 апр 2024 06:59:00 Источник Nasdaq GlobeNewswire

Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results

06 мар 2024 16:20:00 Источник Nasdaq GlobeNewswire

Generation Bio to Present at the 2024 TD Cowen Health Care Conference

27 фев 2024 06:59:00 Источник Nasdaq GlobeNewswire

Generation Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference

03 янв 2024 16:05:00 Источник Nasdaq GlobeNewswire

Generation Bio Announces Strategic Reorganization to Extend Cash Runway for Development of ctLNP and iqDNA Platforms

29 ноя 2023 06:59:00 Источник Nasdaq GlobeNewswire

Generation Bio Reports Business Highlights and Third Quarter 2023 Financial Results

09 ноя 2023 16:15:00 Источник Nasdaq GlobeNewswire

Generation Bio Announces Demonstration of Highly Selective T Cell Transduction In Vivo with Cell-Targeted LNP Platform

26 окт 2023 06:59:00 Источник Nasdaq GlobeNewswire

Generation Bio Announces Breakthrough in its Non-Viral Genetic Medicine Platform with Novel “Immune-Quiet” DNA

18 окт 2023 06:59:16 Источник Nasdaq GlobeNewswire

Generation Bio to Present at the Jefferies Cell & Genetic Medicine Summit

19 сен 2023 07:30:00 Источник Nasdaq GlobeNewswire

Generation Bio to Present at the Canaccord Genuity 43rd Annual Growth Conference 

03 авг 2023 07:30:00 Источник Nasdaq GlobeNewswire